FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Pfizer Pays $43 Million Over Antibiotic Marketing

[ Price : $8.95]

Pfizer agrees to pay $43 million to 33 states to resolve a multistate fraud investigation into the companys alleged unlawful promo...

Guidance on Product Design Safety Considerations

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance, Safety Considerations for Product Design to Minimize Medication Errors.

Device Product Name Corrected

[ Price : $8.95]

Federal Register Notice: FDA makes a correction to a product name in a 12/7 Federal Register notice for the NeuroPace RNS System.

FDA Accepts Modular PMA Shell for Intercept Plasma

[ Price : $8.95]

FDA accepts a Cerus Corp. modular PMA shell proposal for the Intercept Blood System for plasma.

Lilly Scraps a Phase 3 Tabalumab Study Over Efficacy

[ Price : $8.95]

Eli Lilly stops one of three Phase 3 rheumatoid arthritis registration studies involving tabalumab, an anti-BAFF monoclonal antibo...

30% of Health Care Cost is Wasted: HHS

[ Price : $8.95]

Key federal enforcement officials tell an FDLI Conference panel that 30% of health expenditures are lost to waste, including fraud...

FDA Panel Reclassifies Intra-aortic Balloon Pump Devices

[ Price : $8.95]

FDAs Circulatory System Devices Panel votes to support the agencys reclassification of intra-aortic balloon pump devices for certa...

Now Alli Joins Plan B to Embarrass FDA into Action?

[ Price : $8.95]

Washington commentator Bob Steeves reviews new risk data on orlistat and contrasts its continuing OTC availability to teens with e...

Guidance Out on Design Considerations for Home Use Devices

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance, Design Considerations for Devices Intended for Home Use.

Jail Terms Needed in Health Fraud Cases, Blumberg Says

[ Price : $8.95]

FDA deputy chief counsel for litigation Eric Blumberg calls for greater use of the Park Doctrine and jail terms in healthcare frau...